207 related articles for article (PubMed ID: 27190347)
1. Effect of a sustained difference in hemodialytic clearance on the plasma levels of p-cresol sulfate and indoxyl sulfate.
Camacho O; Rosales MC; Shafi T; Fullman J; Plummer NS; Meyer TW; Sirich TL
Nephrol Dial Transplant; 2016 Aug; 31(8):1335-41. PubMed ID: 27190347
[TBL] [Abstract][Full Text] [Related]
2. Removal of P-cresol sulfate by hemodialysis.
Martinez AW; Recht NS; Hostetter TH; Meyer TW
J Am Soc Nephrol; 2005 Nov; 16(11):3430-6. PubMed ID: 16120820
[TBL] [Abstract][Full Text] [Related]
3. Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration.
Krieter DH; Hackl A; Rodriguez A; Chenine L; Moragues HL; Lemke HD; Wanner C; Canaud B
Nephrol Dial Transplant; 2010 Jan; 25(1):212-8. PubMed ID: 19755476
[TBL] [Abstract][Full Text] [Related]
4. Removal of the protein-bound solutes indican and p-cresol sulfate by peritoneal dialysis.
Pham NM; Recht NS; Hostetter TH; Meyer TW
Clin J Am Soc Nephrol; 2008 Jan; 3(1):85-90. PubMed ID: 18045861
[TBL] [Abstract][Full Text] [Related]
5. Increasing the clearance of protein-bound solutes by addition of a sorbent to the dialysate.
Meyer TW; Peattie JW; Miller JD; Dinh DC; Recht NS; Walther JL; Hostetter TH
J Am Soc Nephrol; 2007 Mar; 18(3):868-74. PubMed ID: 17251385
[TBL] [Abstract][Full Text] [Related]
6. Effect of increasing dietary fiber on plasma levels of colon-derived solutes in hemodialysis patients.
Sirich TL; Plummer NS; Gardner CD; Hostetter TH; Meyer TW
Clin J Am Soc Nephrol; 2014 Sep; 9(9):1603-10. PubMed ID: 25147155
[TBL] [Abstract][Full Text] [Related]
7. Effect of increasing dialyzer mass transfer area coefficient and dialysate flow on clearance of protein-bound solutes: a pilot crossover trial.
Luo FJ; Patel KP; Marquez IO; Plummer NS; Hostetter TH; Meyer TW
Am J Kidney Dis; 2009 Jun; 53(6):1042-9. PubMed ID: 19394728
[TBL] [Abstract][Full Text] [Related]
8. Removal of Protein-Bound Uremic Toxins during Hemodialysis Using a Binding Competitor.
Madero M; Cano KB; Campos I; Tao X; Maheshwari V; Brown J; Cornejo B; Handelman G; Thijssen S; Kotanko P
Clin J Am Soc Nephrol; 2019 Mar; 14(3):394-402. PubMed ID: 30755453
[TBL] [Abstract][Full Text] [Related]
9. Residual Function Effectively Controls Plasma Concentrations of Secreted Solutes in Patients on Twice Weekly Hemodialysis.
Leong SC; Sao JN; Taussig A; Plummer NS; Meyer TW; Sirich TL
J Am Soc Nephrol; 2018 Jul; 29(7):1992-1999. PubMed ID: 29728422
[No Abstract] [Full Text] [Related]
10. Contribution of residual function to removal of protein-bound solutes in hemodialysis.
Marquez IO; Tambra S; Luo FY; Li Y; Plummer NS; Hostetter TH; Meyer TW
Clin J Am Soc Nephrol; 2011 Feb; 6(2):290-6. PubMed ID: 21030575
[TBL] [Abstract][Full Text] [Related]
11. Serum concentrations of p-cresyl sulfate and indoxyl sulfate, but not inflammatory markers, increase in incident peritoneal dialysis patients in parallel with loss of residual renal function.
Viaene L; Meijers BK; Bammens B; Vanrenterghem Y; Evenepoel P
Perit Dial Int; 2014; 34(1):71-8. PubMed ID: 24179107
[TBL] [Abstract][Full Text] [Related]
12. p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients.
Meijers BK; De Loor H; Bammens B; Verbeke K; Vanrenterghem Y; Evenepoel P
Clin J Am Soc Nephrol; 2009 Dec; 4(12):1932-8. PubMed ID: 19833905
[TBL] [Abstract][Full Text] [Related]
13. Limited reduction in uremic solute concentrations with increased dialysis frequency and time in the Frequent Hemodialysis Network Daily Trial.
Sirich TL; Fong K; Larive B; Beck GJ; Chertow GM; Levin NW; Kliger AS; Plummer NS; Meyer TW;
Kidney Int; 2017 May; 91(5):1186-1192. PubMed ID: 28089366
[TBL] [Abstract][Full Text] [Related]
14. Meta-Analysis of the Associations of p-Cresyl Sulfate (PCS) and Indoxyl Sulfate (IS) with Cardiovascular Events and All-Cause Mortality in Patients with Chronic Renal Failure.
Lin CJ; Wu V; Wu PC; Wu CJ
PLoS One; 2015; 10(7):e0132589. PubMed ID: 26173073
[TBL] [Abstract][Full Text] [Related]
15. Increasing the removal of protein-bound uremic toxins by liposome-supported hemodialysis.
Shi Y; Wang Y; Ma S; Liu T; Tian H; Zhu Q; Wang W; Li Y; Ding F
Artif Organs; 2019 May; 43(5):490-503. PubMed ID: 30375673
[TBL] [Abstract][Full Text] [Related]
16. Differences in Dialysis Efficacy Have Limited Effects on Protein-Bound Uremic Toxins Plasma Levels over Time.
Krieter DH; Kerwagen S; Rüth M; Lemke HD; Wanner C
Toxins (Basel); 2019 Jan; 11(1):. PubMed ID: 30654454
[TBL] [Abstract][Full Text] [Related]
17. Selectively increasing the clearance of protein-bound uremic solutes.
Sirich TL; Luo FJ; Plummer NS; Hostetter TH; Meyer TW
Nephrol Dial Transplant; 2012 Apr; 27(4):1574-9. PubMed ID: 22231033
[TBL] [Abstract][Full Text] [Related]
18. Results of the HEMO Study suggest that p-cresol sulfate and indoxyl sulfate are not associated with cardiovascular outcomes.
Shafi T; Sirich TL; Meyer TW; Hostetter TH; Plummer NS; Hwang S; Melamed ML; Banerjee T; Coresh J; Powe NR
Kidney Int; 2017 Dec; 92(6):1484-1492. PubMed ID: 28739139
[TBL] [Abstract][Full Text] [Related]
19. High correlation between clearance of renal protein-bound uremic toxins (indoxyl sulfate and p-cresyl sulfate) and renal water-soluble toxins in peritoneal dialysis patients.
Huang WH; Hung CC; Yang CW; Huang JY
Ther Apher Dial; 2012 Aug; 16(4):361-7. PubMed ID: 22817125
[TBL] [Abstract][Full Text] [Related]
20. Extended Duration Nocturnal Hemodialysis and Changes in Plasma Metabolite Profiles.
Kalim S; Wald R; Yan AT; Goldstein MB; Kiaii M; Xu D; Berg AH; Clish C; Thadhani R; Rhee EP; Perl J
Clin J Am Soc Nephrol; 2018 Mar; 13(3):436-444. PubMed ID: 29444900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
